Neonatal thrombocytopenia: causes and management.

Area of Science:

• Neonatology
• Hematology

Background:

• Neonatal thrombocytopenia is a frequent clinical issue.
• Early-onset thrombocytopenia (first 72 hours) often stems from placental insufficiency and typically resolves spontaneously.
• Late-onset thrombocytopenia (after 72 hours) is frequently associated with sepsis or necrotizing enterocolitis, presenting as more severe and prolonged cases.

Purpose of the Study:

• To review the clinical presentation and management of neonatal thrombocytopenia.
• To highlight the need for evidence-based guidelines for platelet transfusion therapy.

Main Methods:

• Literature review of neonatal thrombocytopenia.
• Analysis of clinical characteristics based on onset time.
• Discussion of current treatment modalities.

Main Results:

• Two distinct patterns of neonatal thrombocytopenia exist based on timing of onset.
• Early onset is generally less severe and self-limiting.
• Late onset is associated with significant morbidity and requires intervention.

Conclusions:

• Platelet transfusion is the primary treatment for severe neonatal thrombocytopenia.
• Further clinical trials are essential to establish safe thresholds for platelet counts and identify neonates who will benefit from treatment.